| 15:30 | Infectious uveitis secondary to immunosuppression : Real-life experience from Montreal, Canada | HAENSLI C | ||
| 15:38 | Questions / Discussion | |||
| 15:40 | Biosimilars in uveitis | READ R | ||
| 15:48 | Questions / Discussion | |||
| 15:50 | Systemic anti-IL-6 therapy in uveitis | FORTIN E | ||
| 15:58 | Questions / Discussion | |||
| 16:00 | Economic evaluation of DMARDs and biologics for treatment of non-infectious uveitis: A Canadian Perspective | DERZKO-DZULYNSKY L | ||
| 16:08 | Questions / Discussion | |||
| 16:10 | Outcomes of Immunosuppression in Paediatric Patients with Non-Infectious Uveitis: A Real-World Experience | VADBONCOEUR J | ||
| 16:18 | Questions / Discussion | |||
| 16:20 | Personalized approach to immunosuppression | PICHI F | ||
| 16:28 | Questions / Discussion | |||
| 16:30 | End of Session | |||